Applied Biology, Inc.
🇺🇸United States
Clinical Trials
23
Active:0
Completed:9
Trial Phases
4 Phases
Early Phase 1:1
Phase 1:1
Phase 3:10
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 3
10 (52.6%)Not Applicable
7 (36.8%)Early Phase 1
1 (5.3%)Phase 1
1 (5.3%)Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)
Not Applicable
Not yet recruiting
- Conditions
- CanitiesGrey Hair
- Interventions
- Drug: Placebo Topical Solution
- First Posted Date
- 2025-09-10
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT07166354
Pharmacokinetic Study of Topical Phenylephrine
Phase 1
Recruiting
- Conditions
- Chemotherapy Induced AlopeciaChemotherapy Side Effects
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-10-03
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT07033845
- Locations
- 🇮🇹
University of Rome ("G. Marconi"), Rome, Italy
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
Phase 3
Not yet recruiting
- Conditions
- Chemotherapy Induced AlopeciaChemotherapy Side Effects
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT06762548
- Locations
- 🇮🇹
University of Rome ("G. Marconi"), Rome, Italy
Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)
Phase 3
Not yet recruiting
- Conditions
- CanitiesGrey Hair
- Interventions
- Drug: Placebo Topical Solution
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT06745336
Clinical Study of DA-001 as a Treatment for Telogen Effluvium
Phase 3
Not yet recruiting
- Conditions
- Telogen Effluvium
- Interventions
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT06648850
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found